Form 4 for ORGO Organogenesis Holdings Inc.
Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0001062993-22-004802 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-17 | 2022-02-16 | ORGO | Grow Brian | Chief Commercial Off | F - Tax | $7.78 | -799 | 88.9K | -0.9% | -$6,216 |
| D | 2022-02-17 | 2022-02-15 | ORGO | Grow Brian | Chief Commercial Off | A - Grant | $0.00 | +45.1K | 89.7K | +101% | $0 |
| D | 2022-02-17 | 2022-02-15 | ORGO | Grow Brian | Chief Commercial Off | A - Grant | $0.00 | +107.1K | 107.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-02-16 | F | D | 799 | $7.78 | 88,916 | D | — | — | |
| 2 | Common | Class A Common Stock | 2022-02-15 | A | A | 45,143 | $0.00 | 89,715 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-02-15 | A | A | 107,063 | $0.00 | 107,063 | D | $8.03 · — to 2032-02-15 | 107,063 Class A Common Stock | (F2) The option becomes exercisable in equal annual installments over four years beginning February 15, 2022. |